Uricult® Control Box

Quality Control for Uricult Urine Culture Paddles. Each box contains a positive and a negative control plus diluent.

Ordering Information




Uricult® Control Box

2 x 99ml


- OR -

• COVID-19 Anterior nasal swab – Sensitivity 93.8%, Specificity 100%
• COVID-19 Nasopharyngeal – Sensitivity 93.1%, Specificity 100%
• Flu A – Sensitivity 91.4%, Specificity 95.7%
• Flu B – Sensitivity 87.6%, Specificity 95.9%
• FDA Emergency Use Authorization (EUA)
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort

Uricult® Control Kit #200030
Box Dimensions: Determined By Order
Box Weight: Determined By Order
Ship Case Weight: Determined By Order
Ship Case Dimensions: Determined By Order
Boxes Per Ship Case: Determined By Order
Boxes Per Pallet: Determined By Order
Pallet Dimensions: Determined By Order

Our products are developed and manufactured in the USA under ISO, FDA, cGMP, and CE mark guidelines. BDSC’s team of expert sales, technical and customer service professionals are devoted to delivering the highest quality of service to our partners.

BDSC is an authorized distributor delivering high quality rapid point of care testing products to the healthcare industry. BDSC’s line of innovative products is used by clinicians to aid in the detection of medical conditions which include Infectious Disease, Women’s Health, and Cardiac Markers. The vast majority of our products are developed and manufactured in the USA under ISO, FDA, cGMP, and CE mark guidelines. BDSC’s team of sales, technical, and customer service professionals deliver the highest quality of service and support to our customers.

BDSC Company offers a range of ordering options. If you would like to speak to a BDSC expert immediately, contact us on 800-592-1041. If you prefer to enquire online, please click on ‘Get A Quote’ above.

More from BDSC Catalogue



The Preferred In-Office Urine Culture System.


Status™ BTA

A Rapid Test for the Qualitative Detection of Bladder Tumor Associated Antigen in Human Urine.

Infectious Disease

Status™ COVID-19/Flu A&B

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SAR-CoV-2, Influenza TypeA and Type B Antigen from anterior nasal and nasopharyngeal swab specimens.

BDSC - Quality you can depend on.

BDSC Offers Professional Pharmaceutical Sales, Medical Supply Solutions, & Unparalleled Customer Service. Contact Us For More Information.
Contact Us
Copyright© 2023 BDSC Company - All Rights Reserved.